A review on Bhallatak in Management of lifestyle disorder Prameha (diabetes mellitus)
Keywords:
Bhallatak, semicarpus anacardium, Prameha, Diabetes mellitus, lifestyle diseases, Anti hyperglycemic agents, InsulinAbstract
Lifestyle diseases are diseases linked with the way people live their life. This is commonly caused by lack of physical activity, unhealthy eating, lack of organic (food-fruits-vegetables), irregular daily routine i.e. (sleep, irregular meals, toilet) etc. Alcohol intake, drug consumption and smoking are also responsible factors. Diseases that impact on our lifestyle are heart disease, stroke, obesity and type II diabetes. Diabetes mellitus is a metabolic disorder characterized by hyperglycemia due to defect in insulin secretion, action, or both. Liver plays an important role in the glucose homeostasis through glycolysis, glycogenesis, and gluconeogenesis.
Semicarpus anacardium (‘Bhallatak’) has been used in various traditional system of medicines for various ailments since ancient times. Its nut contains a variety of biologically active compounds such as bioflavonoid, phenolic compounds, bhilawanols, minerals, vitamins and amino acids, which show various medicinal properties. The fruit and nut extract shows various activities like hypoglycemic anti-artherogenic, anti-inflammatory, antioxidant, antimicrobial, anti-reproductive, CNS stimulant, anti-carcinogenic and hair growth promoter. Research study revealed, the ethanolic extract of SA (100 mg/kg) reduced the blood glucose of normal rats. Bhallatak was able to restore the altered activities of the enzymes involved in carbohydrate metabolism and energy production.
Downloads
References
2.Melmed S, Polonsky KS, Larsen PR, Kronenberg HM (eds.). Williams textbook of endocrinology (12th ed.). Philadelphia: Elsevier/Saunders. pp. 1371–1435. ISBN 978-1-4377-0324-5.
3.Visscher TL, Snijder MB, Seidell JC (2009). "Epidemiology: Definition and Classification of Obesity". In Kopelman PG, Caterson ID, Dietz WH. Clinical Obesity in Adults and Children (3rd ed.). Wiley-Blackwell. p. 7. ISBN 978-1-4443-0763-4
4.Shoback DG, Gardner D, eds. (2011). "Chapter 17". Greenspan's basic & clinical endocrinology (9th ed.). New York: McGraw-Hill Medical. ISBN 978-0-07-162243-1.
5. "Diabetes Fact sheet N°312". WHO. October 2013. Archived from the original on 26 August 2013. Retrieved 25 March 2014.
6. Fauci et 61al,Harrisons Internal Medicine , Chapter 338, Page No. 2271-75, 17th Edition,Mc Graw Hill medical,2008.9
7. Brown JB, Nichols GA, Glauber HS, Bakst A. Ten-year follow-up of antidiabetic drug
use, nonadherence, and mortality in a defined population with type 2 diabetes mellitus.
Clin Ther. 1999; 21(6):1045-1057.
8. Rippe RS, Irwin JM, eds. (2010). Manual of intensive care medicine (5th ed.). Wolters Kluwer Health/Lippincott Williams & Wilkins. p. 549. ISBN 9780781799928.
9. Kirtikar KR, Basu BD. Indian medicinal plants. Vol. 3. Dehradun, India: International Booksellers and Publishers; 1975. pg. 667.
10. Bhitre MJ, Patil S, Kataria M, Anwikar S, Kadri H. Antiinflammatory activity of the Bhallatak.
11. Singh M.P. and Himadri Panda, Medicinal herbs with their formulations, Vol.II, Daya Publication House, Delhi, 2005. pg758.)
12. Database on medicinal plant used in ayurveda & siddha Vol 5, CCRAS Dept. of Ayush,Ministry of health and family welfare GOI. 2008, PP 9-14)
12a. Mishra Brahmashankar,Bhawprakash Part I, Dhatwadi Varga/verce191, 206, Reprint edition tion 2013, Chowkhamba Sanskrit Bhawan Varanasi,page 629,634.
12b. Dr. Indradev Tripathi. Raj Nighantu. 5th edition. Chaukhamba krishnadas academy Varanasi.2010 pg.353
12c. Ayurvedodharaka Shaligram Vaishya. Shaligram Nighantu. Khemraj Shrikrishnadas, Shri Venkateshwar press, Mumbai.
12d. Acharya Priyawat sharma, Dr. Guruprasad sharma. Kaiyadeva Nighantu, 1st edition. Chaukhamba Orientalia, Varanasi.
13.Shukla V, Tripathi RD, Charak Samhita of Agnivesha,Reprint edi-2015,Choukhamba Sanskrit pratishthan Delhi,Chikitsasthan1/2, pp.13-15, Rasayan adhyay, prankamiya pad; pg21-24
14. Sharma Anant ram,Sushrut Samhita of Sushruta,Chaukhamba surbharati prakashan, 1st edition2013,Chikitsasthan 6/17,9/7 pp.231,251; kalpsthan 1/69-71.pg 513.
15. Tripathi Brahmanand, Ashtang Hridaya of Vagbhat, Choukhamba Sanskrit pratishthan Delhi, Reprint edition 2011;Chikitsasthan 1/154 .pg.574.
16.Sadanand sharma,Rastarangini,motilal banarasidas Delhi ,11th edition,1979; pg.735
17. Pilay VV, Modern Medical Toxicology,4th edition 2013,Jaypee brothers medical publishers, pg. 124-125
18. Pillay VV, Modern Medical Toxicology,4th edition 2013,Jaypee brothers medical publishers, pg. 124-125
Downloads
Published
How to Cite
Issue
Section
License
I declare (on behalf of me and my co-authors) that the submitted manuscript titled has not previously been published and is not currently being considered elsewhere for publication in another journal and that I am (we are) the sole owner(s) of the manuscript thereof and of all rights, title, and interest therein. All agreed to the terms and conditions, Privacy Policy, which is declared on Journal Website http://www.ayurline.in and online filled (uploaded) form.
Please read following declaration cum Agreement Carefully.:
I declare (on behalf of me and my co-authors) that the submitted manuscript titled has not previously been published and is not currently being considered elsewhere for publication in another journal and that I am (we are) the sole owner(s) of the manuscript thereof and of all rights, title, and interest therein.
I (We) agree (on behalf of me and my co-authors) to the following:
1- I (we) hereby assign to the publisher of the journal. Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) the right to (Electronically and print) publish on website www.ayurline.in and distribute the said manuscript and to create a derivative print work from the said manuscript. The assignment shall be effective so long as the manuscript is available on online networks.
2- I (we) shall remain the owner of the copyright in said manuscript. I (we) may publish the manuscript in any other journal or medium but such publication must include the notice that the manuscript was first published by Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) Journals including reference to the corresponding issue.
3- I (we) agree to hold the publisher of the Journal, Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) harmless for any unauthorized use of the paper by the journal subscribers.
4- I (we) confirm that I (we) have obtained all the necessary all permissions to include in the paper items such as quotations, figures, and the results of government-sponsored research/private or individual publishers/owners.
5- I (we) enclose where necessary written permission of authors and publishers to use any copyright material (previously published figures and tables).
6- I (we) confirm that after the publication of my (our) manuscript in Ayurline: International Journal of Research in Indian Medicine (IJ-RIM), the publisher has the sole authority of the paper/Research Article. The publisher has the authority to use the content of the whole paper or part of it, in an edited book, or other mediums or withdraw (unpublish) the article without the permission of authors.
8- If I / We found victims of plagiarism, (साहित्यिक चोरी) (e.g. text, images, videos etc.) I/ We sole responsible for such legal matters. I/We also declared that the Chief Editor/Publisher, Editorial Board of this Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) Journal does not have any responsibility for plagiarism. Publisher shall not become any party in any legal matter and if any case is filed in court against plagiarisms or any copyright-related issues all expenses/Penalties should be paid/borne by me/we (Authors). I shall be obliged to pay all the costs of the court case if any happened in future.
7 -I voluntarily agreed to pay the necessary non-refundable evaluation fees of the my article, which are not the publication Charges.
8 - All disputes subject to Kurla, Mumbai court jurisdiction. This Copyright Licensing Agreement comes into force the day of sending this completed electronic form.